OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, et al.
Heliyon (2021) Vol. 7, Iss. 10, pp. e08124-e08124
Open Access | Times Cited: 17

Showing 17 citing articles:

Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 54

Virus‐like particles as powerful vaccination strategy against human viruses
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Mohammed A. Almalki, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 17

A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 15

State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic
Rahul Bhattacharjee, Ankit Kumar Dubey, Archisha Ganguly, et al.
OpenNano (2022) Vol. 8, pp. 100078-100078
Open Access | Times Cited: 14

Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
Marcel Jaron, Michael Lehky, M Zara, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 14

Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?
Reeshu Gupta, Kajal Arora, Nupur Mehrotra Arora, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 17-28
Open Access

A BRIEF DESCRIPTION OF COVID-19 PULMONARY VIRAL INFECTION AND REPURPOSING OF DRUGS FOR ITS TREATMENT
Manisha Patel, Rupa Mazumder, KAMAL KANT KAUSHIK, et al.
International Journal of Applied Pharmaceutics (2022), pp. 22-31
Open Access | Times Cited: 3

Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review
Fatima Akram, Ikram ul Haq, Amna Aqeel, et al.
Journal of Virological Methods (2021) Vol. 300, pp. 114375-114375
Open Access | Times Cited: 4

Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice
Vedita Anand Singh, Sanket Nehul, Chandra Shekhar Kumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

VLP-ELISA for the Detection of IgG Antibodies against Spike, Envelope, and Membrane Antigens of SARS-CoV-2 in Indian Population
Dilip Kumar, Sourav Singha Roy, Ruchir Rastogi, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 743-743
Open Access | Times Cited: 1

Yeast and Virus-like Particles: A Perfect or Imperfect Couple?
Sara Brachelente, Alvaro Galli, Tiziana Cervelli
Applied Microbiology (2023) Vol. 3, Iss. 3, pp. 805-825
Open Access | Times Cited: 1

First Full-Length Cloning of Human NaV1.7 in S. Cerevisiae-Based Novel D-Crypt Platform for its High-Scale Production
Kajal Arora, Sourav Roy, Sudhir Kumar, et al.
Trends in Sciences (2023) Vol. 21, Iss. 2, pp. 7232-7232
Open Access | Times Cited: 1

Advances in heterologous protein expression strategies in yeast and insect systems
Meenakshi Singh, Smita Gupta, Arun Rawat, et al.
Elsevier eBooks (2022), pp. 13-30
Closed Access | Times Cited: 2

Advances in the delivery of COVID-19 vaccines
Kevin Ita
American Journal of Biopharmacy and Pharmaceutical Sciences (2022) Vol. 2, pp. 5-5
Open Access

Page 1

Scroll to top